Frontiers in medicine · 2026
Evaluating the value of lactic dehydrogenase in anti-MDA5-positive Dermatomyositis associated with interstitial lung disease.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Huang Wenhan, Ren Feifeng, Qian Kechen, Jiang Yanqiu, Zhang Yichen, Tang Lin
Аннотация
OBJECTIVE: This retrospective cohort study aimed to investigate the relationship between lactic dehydrogenase (LDH) and anti-melanoma differentiation-associated gene 5 antibodies-positive dermatomyositis (anti-MDA5-positive DM) associated with interstitial lung disease (ILD).
METHOD: A total of 168 anti-MDA5-positive DM patients with ILD underwent comprehensive evaluation, including LDH, anti-Ro-52 antibodies, serum ferritin determination, and lung high-resolution computed tomography (CT).
RESULTS: The levels of LDH were significantly elevated in anti-MDA5-positive DM patients compared with the control group (p < 0.01). Anti-Ro-52-positive patients exhibited significantly higher LDH levels than anti-Ro-52-negative patients (p < 0.01). Patients with elevated serum ferritin exhibited markedly increased LDH levels compared with those with lower serum ferritin (p < 0.01). After treatment, LDH levels significantly increased in patients with ILD deterioration (p < 0.01), whereas LDH levels decreased in patients with ILD amelioration or stabilization (p < 0.01). The LDH levels were significantly elevated in the death group compared to the survival group before treatment (p = 0.02).
CONCLUSION: (1) The LDH levels were affected by anti-Ro-52 antibodies and serum ferritin. (2) The severity of ILD in anti-MDA5-positive DM patients was positively correlated with LDH, suggesting that LDH might serve as an effective assessment indicator to evaluate the changes in ILD in these patients. (3) Elevated LDH levels were a crucial indicator of poor prognosis in anti-MDA5-positive DM patients, warranting close attention from rheumatologists.
METHOD: A total of 168 anti-MDA5-positive DM patients with ILD underwent comprehensive evaluation, including LDH, anti-Ro-52 antibodies, serum ferritin determination, and lung high-resolution computed tomography (CT).
RESULTS: The levels of LDH were significantly elevated in anti-MDA5-positive DM patients compared with the control group (p < 0.01). Anti-Ro-52-positive patients exhibited significantly higher LDH levels than anti-Ro-52-negative patients (p < 0.01). Patients with elevated serum ferritin exhibited markedly increased LDH levels compared with those with lower serum ferritin (p < 0.01). After treatment, LDH levels significantly increased in patients with ILD deterioration (p < 0.01), whereas LDH levels decreased in patients with ILD amelioration or stabilization (p < 0.01). The LDH levels were significantly elevated in the death group compared to the survival group before treatment (p = 0.02).
CONCLUSION: (1) The LDH levels were affected by anti-Ro-52 antibodies and serum ferritin. (2) The severity of ILD in anti-MDA5-positive DM patients was positively correlated with LDH, suggesting that LDH might serve as an effective assessment indicator to evaluate the changes in ILD in these patients. (3) Elevated LDH levels were a crucial indicator of poor prognosis in anti-MDA5-positive DM patients, warranting close attention from rheumatologists.